RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS
- VernacularTitle:以表阿霉素为主治疗恶性肿瘤70例的疗效
- Author:
De SHI
- Publication Type:Journal Article
- Keywords:
Epirubicin;
Malignant tumor;
Chemotherapy
- From:
Journal of Chongqing Medical University
1986;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
A prospective study on a new antibictic antineoplastic drug Epirubicin (pharm-orubicin,EPI)in the management of malignant tumors was carried out from February 1987 to February 1990.Diseases divided into three groups, ( 1 ) 47 cases, recurrences/metastases of the initial tumor, after treatment of operation, radiation or other antineoplastic drug; (2)8 cases, after palliative operation; (3)15cases, after radical operation.The response rate was 92.9% for maligcant lymphoma. The EPI containing regimens were also effective in the patients with gastre-intestinal cancer, breast can- eer and sarcoma, etc. The main side effectsof EPI containing regimens were also analysed, and the dose-limiting toxicity was still bone marrow depression. Only one patient showed I A-V block. Tie role of EPI in chemotherapy of common malignancies was discussed
